Skip to content
healthcare.dev
Get a free key

Azulfidine EN-tabs

NDC 0013-0102, Sulfasalazine, tablet, delayed release, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0013-0102
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA007073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0013-0102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SULFASALAZINE500 mg/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
0013-0102-50000130102501 BOTTLE in 1 CARTON (0013-0102-50) / 100 TABLET, DELAYED RELEASE in 1 BOTTLE
0013-0102-60000130102601 BOTTLE in 1 CARTON (0013-0102-60) / 300 TABLET, DELAYED RELEASE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b9ef541a-93c8-4428-ba45-398aa0b327d1

Use it

Look up 0013-0102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0013-0102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0013-0102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.